Skip to content

Toxic effect of travoprost of the ocular surface

Toxic effect of travoprost of the ocular surface

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006598
Enrollment
Unknown
Registered
2015-06-16
Start date
2015-06-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Toxic effect of drug on the ocular surface

Interventions

2:drug treatment

Sponsors

Eye institute of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Twenty four healthy volunteers who were aged less than 40 years without systemic and ocular diseases were recruited for this study.

Exclusion criteria

Exclusion criteria: Subjects with regular use of any eyedrops or contact lenses were excluded from the study. Subjects were also excluded if they were of childbearing potential not using reliable means of birth control, pregnant or lactating females, or unwilling to accept minimal risk of unilateral iris or eyelash changes potentially associated with the study medications.

Design outcomes

Primary

MeasureTime frame
corneal sensitivity;aqueous tear production;fluorescein staining;tear break-up time;structure of central cornea;

Countries

China

Contacts

Public ContactWensheng Chen
cwensheng@hotmail.com+86 15959231369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026